查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612963

截肢后慢性疼痛管理市场：按类型、治疗类型、最终用户划分 - 全球预测 2025-2030

Chronic Post-Amputation Pain Management Market by Type (Neuroma Pain, Phantom Limb Pain, Stump Pain), Treatment Type (Medication, Neuromodulation Techniques, Surgical Interventions), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年截肢后慢性疼痛管理市场价值为56.5亿美元，预计到2024年将达到59.6亿美元，复合年增长率为5.66%，到2030年将达到83.1亿美元，预计将达到1000万美元。

截肢后慢性疼痛管理总结了缓解截肢后持续疼痛的策略和治疗方法。这个市场对于改善经常遭受幻肢痛或残肢痛的截肢者的生活品质至关重要。截肢者面临巨大的身体和心理挑战，其医疗需求未被满足，凸显了有效疼痛管理的必要性。应用范围从止痛药和抗忧郁剂等药物到神经阻断、脊髓刺激和经皮神经电刺激等进阶治疗。最终用途主要包括医疗保健提供者、復健中心和疼痛管理诊所。

主要市场统计
基准年[2023] 56.5亿美元
预测年份 [2024] 59.6亿美元
预测年份 [2030] 83.1亿美元
复合年增长率（%） 5.66%

由于糖尿病和周边动脉疾病盛行率上升，截肢人数不断增加，影响了市场的成长。疼痛管理疗法的技术进步、对个人化医疗的重视以及人工智慧在疼痛结果预测模型开发中的整合正在创造潜在的商机。为了利用这些机会，公司应专注于探索合作伙伴关係和新型药物输送系统。然而，高昂的治疗费用、糟糕的报销政策以及疼痛评估的复杂性等障碍限制了市场的扩张。

挑战包括高误诊率和使治疗方法复杂化的疼痛心理方面。为了实现业务成长，创新应针对非鸦片类疼痛管理解决方案和允许远端监测疼痛程度的数位疗法。虚拟实境和神经调节技术的引入是有前途的研究途径。竞争激烈且分散的市场需要策略重点关注利基领域，例如儿科疼痛管理和针对特定患者群体的干预措施。对临床试验和患者教育的持续投资可以提高治疗的可接受性并加速市场渗透。为了应对这一不断变化的形势，公司必须优先考虑以患者为中心的解决方案和强大的相关人员协作。

市场动态：揭示快速发展的截肢后慢性疼痛管理市场的关键市场洞察

供需的动态交互作用正在改变截肢后慢性疼痛管理市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 提高对疼痛管理方案的认识并改善医疗基础设施
    • 对药物和非药物疼痛管理疗法的偏好日益增加
    • 政府支持政策和医疗报销制度
  • 市场限制因素
    • 昂贵的治疗费用
  • 市场机会
    • 神经调节技术的不断进步
    • 需要以患者为中心的医疗保健模式，强调个人化治疗计划
  • 市场挑战
    • 专业医护人员短缺及药物副作用问题

波特五力：驾驭截肢后慢性疼痛管理市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解截肢后慢性疼痛管理市场的外部影响

外部宏观环境因素在塑造截肢后慢性疼痛管理市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解截肢后慢性疼痛管理市场的竞争格局

对截肢后慢性疼痛管理市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵截肢后慢性疼痛管理市场供应商的绩效评估

FPNV 定位矩阵是评估截肢后慢性疼痛管理市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划截肢后慢性疼痛管理市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，截肢后慢性疼痛管理市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 提高对疼痛管理方法的认识并改善医疗基础设施
      • 人们对药物和非药物疼痛管理疗法越来越感兴趣。
      • 政府支持政策和医疗报销
    • 抑制因素
      • 治疗方案成本高
    • 机会
      • 神经调节技术的不断进步
      • 需要以患者为中心的医疗保健模式，强调个人化治疗计划
    • 任务
      • 专业医护人员短缺、药物副作用等问题
  • 市场区隔分析
    • 类型：对幻肢痛管理以缓解疼痛和提高生活品质的需求不断增长
    • 最终用途：医院截肢后慢性疼痛管理的需求不断增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章截肢后慢性疼痛管理市场：依类型

  • 神经瘤疼痛
  • 幻肢痛
  • 切面疼痛

第七章依治疗类型分類的截肢后慢性疼痛管理市场

  • 药物治疗
  • 神经调节技术
  • 手术介入
  • 治疗
    • 镜子疗法
    • 物理治疗
    • 心理治疗

第八章截肢后慢性疼痛管理市场：依最终用途分类

  • 居家护理
  • 医院
  • 疼痛诊所
  • 復健中心

第九章美洲截肢后慢性疼痛管理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区截肢后慢性疼痛管理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲截肢后慢性疼痛管理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Trinity Capital 投资 Neuros Medical 以加强截肢者的疼痛管理
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Advanced Arm Dynamics, Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • ATI Physical Therapy
  • B. Braun Melsungen AG
  • Einstein Healthcare Network
  • GlaxoSmithKline PLC
  • Memorial Healthcare System
  • Novartis AG
  • Pfizer Inc.
  • Physiopedia
  • Propel Physiotherapy
  • Select Medical Corporation
  • Smart Solutions Rehab Group
  • Teva Pharmaceutical Industries Ltd.
  • The Rehabilitation Hospital of Montana
Product Code: MRR-99555D550529

The Chronic Post-Amputation Pain Management Market was valued at USD 5.65 billion in 2023, expected to reach USD 5.96 billion in 2024, and is projected to grow at a CAGR of 5.66%, to USD 8.31 billion by 2030.

Chronic Post-Amputation Pain Management encapsulates the strategies and treatments designed to alleviate persistent pain experienced by individuals following limb amputation. This market is critical in enhancing the quality of life for amputees, who often suffer from phantom limb pain or residual limb pain. The necessity of effective pain management is underscored by the unmet medical needs of amputees facing significant physical and psychological challenges. Applications range from pharmaceutical medications, such as analgesics and antidepressants, to advanced therapies like nerve blocks, spinal cord stimulation, and transcutaneous electrical nerve stimulation. The end-use scope primarily includes healthcare providers, rehabilitation centers, and specialized pain management clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 5.65 billion
Estimated Year [2024] USD 5.96 billion
Forecast Year [2030] USD 8.31 billion
CAGR (%) 5.66%

The market growth is being influenced by an increasing number of amputation surgeries due to rising incidences of diabetes and peripheral arterial disease. Technological advancements in pain management therapies, a greater emphasis on personalized medicine, and the integration of artificial intelligence in developing predictive models for pain outcomes are creating potential opportunities. Companies should focus on collaborative partnerships and exploring novel drug-delivery systems to tap into these opportunities. However, barriers such as high treatment costs, inadequate reimbursement policies, and the complexity of pain assessment limit market expansion.

Challenging factors include the high rate of misdiagnosis and the psychological aspect of pain that complicates treatment regimens. For business growth, innovation should target non-opioid pain management solutions and digital therapeutics that can monitor pain levels remotely. Incorporation of virtual reality and neuromodulation technologies offers promising research avenues. The market is competitive and fragmented, requiring a strategic focus on niche segments like pediatric pain management and tailored interventions for specific patient demographics. Continued investment in clinical trials and patient education can enhance treatment acceptance and drive market penetration. To navigate this evolving landscape, companies must prioritize patient-centric solutions and robust stakeholder collaboration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Chronic Post-Amputation Pain Management Market

The Chronic Post-Amputation Pain Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness of pain management options and better healthcare infrastructure
    • Increasing preference for pharmacological and non-pharmacological pain management therapies
    • Supportive government policies and healthcare reimbursement
  • Market Restraints
    • High cost of treatment options
  • Market Opportunities
    • Ongoing advancements in neuromodulation technologies
    • Need for patient-centric healthcare models emphasizing personalized treatment plans
  • Market Challenges
    • Limited availability of specialized medical professionals and issues associated with medication side effects

Porter's Five Forces: A Strategic Tool for Navigating the Chronic Post-Amputation Pain Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Chronic Post-Amputation Pain Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Chronic Post-Amputation Pain Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Chronic Post-Amputation Pain Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Chronic Post-Amputation Pain Management Market

A detailed market share analysis in the Chronic Post-Amputation Pain Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Chronic Post-Amputation Pain Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Chronic Post-Amputation Pain Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Chronic Post-Amputation Pain Management Market

A strategic analysis of the Chronic Post-Amputation Pain Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.

Market Segmentation & Coverage

This research report categorizes the Chronic Post-Amputation Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Neuroma Pain, Phantom Limb Pain, and Stump Pain.
  • Based on Treatment Type, market is studied across Medication, Neuromodulation Techniques, Surgical Interventions, and Therapy. The Therapy is further studied across Mirror Therapy, Physical Therapy, and Psychological Therapy.
  • Based on End-Use, market is studied across Home Care, Hospitals, Pain Clinics, and Rehabilitation Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness of pain management options and better healthcare infrastructure
      • 5.1.1.2. Increasing preference for pharmacological and non-pharmacological pain management therapies
      • 5.1.1.3. Supportive government policies and healthcare reimbursement
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment options
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in neuromodulation technologies
      • 5.1.3.2. Need for patient-centric healthcare models emphasizing personalized treatment plans
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of specialized medical professionals and issues associated with medication side effects
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
    • 5.2.2. End-Use: Growing need for chronic post-amputation pain management in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chronic Post-Amputation Pain Management Market, by Type

  • 6.1. Introduction
  • 6.2. Neuroma Pain
  • 6.3. Phantom Limb Pain
  • 6.4. Stump Pain

7. Chronic Post-Amputation Pain Management Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Medication
  • 7.3. Neuromodulation Techniques
  • 7.4. Surgical Interventions
  • 7.5. Therapy
    • 7.5.1. Mirror Therapy
    • 7.5.2. Physical Therapy
    • 7.5.3. Psychological Therapy

8. Chronic Post-Amputation Pain Management Market, by End-Use

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospitals
  • 8.4. Pain Clinics
  • 8.5. Rehabilitation Centers

9. Americas Chronic Post-Amputation Pain Management Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Chronic Post-Amputation Pain Management Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Chronic Post-Amputation Pain Management Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Advanced Arm Dynamics, Inc.
  • 3. Aspen Pharmacare Holdings Limited
  • 4. AstraZeneca PLC
  • 5. ATI Physical Therapy
  • 6. B. Braun Melsungen AG
  • 7. Einstein Healthcare Network
  • 8. GlaxoSmithKline PLC
  • 9. Memorial Healthcare System
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Physiopedia
  • 13. Propel Physiotherapy
  • 14. Select Medical Corporation
  • 15. Smart Solutions Rehab Group
  • 16. Teva Pharmaceutical Industries Ltd.
  • 17. The Rehabilitation Hospital of Montana

LIST OF FIGURES

  • FIGURE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMA PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHANTOM LIMB PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STUMP PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY NEUROMODULATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY MIRROR THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. CHRONIC POST-AMPUTATION PAIN MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023